GerdCare is a Digital Therapeutic Company developing a drug-free solution for treatment of Gastro-Esophageal Reflux Disease [GERD].

The eGERD is a non-invasive, self-use medical device, clinically proven to be safe & effectiveGERD is One of the most common digestive disorders, affecting 1B people globally.

Impaired Lower Esophageal Sphincter (LES) allows acidic gastric fluids flow to the esophagus resulting in inflammation, heartburn and chest pain.

Poorly treated GERD can lead to Barrett Disease and Cancer.

PPI treatment for GERD is effective in only 60% of patients using the drug.

Chronic use of PPI’s reduces stomach acidity levels, impairing nutrient absorption; Other Long-term risks include Osteoporosis, Neurological Disorders, Dementia, Kidney disease and Cancer.The eGERD is a user-friendly device, self-applied to abdominal skin at home.

The device is a drug-free, non-invasive digital therapeutic electro-stimulator, generating modulated asymmetrical electrical bursts of pulses synchronized with breathing.Abdominal muscles are contracted in an asymmetrical manner inducing improvement in the functionality of the LES and reducing acid reflux from the stomach to the esophagus.

A proprietary smart phone App controls the eGERD device and generates clinical data stored on the GerdCare cloud.

Collected data is processed to create personalized and optimized treatment.